Design Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DSGN and other ETFs, options, and stocks.About DSGN
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.
CEOPratik Shah
CEOPratik Shah
Employees54
Employees54
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2017
Founded2017
Employees54
Employees54
DSGN Key Statistics
Market cap536.60M
Market cap536.60M
Price-Earnings ratio-7.94
Price-Earnings ratio-7.94
Dividend yield—
Dividend yield—
Average volume314.29K
Average volume314.29K
High today$9.56
High today$9.56
Low today$9.23
Low today$9.23
Open price$9.30
Open price$9.30
Volume135.64K
Volume135.64K
52 Week high$10.31
52 Week high$10.31
52 Week low$2.60
52 Week low$2.60
Stock Snapshot
As of today, Design Therapeutics(DSGN) shares are valued at $9.43. The company's market cap stands at 536.6M, with a P/E ratio of -7.94.
As of 2025-12-14, Design Therapeutics(DSGN) stock has fluctuated between $9.23 and $9.56. The current price stands at $9.43, placing the stock +2.2% above today's low and -1.4% off the high.
Design Therapeutics(DSGN) shares are trading with a volume of 135.64K, against a daily average of 314.29K.
In the last year, Design Therapeutics(DSGN) shares hit a 52-week high of $10.31 and a 52-week low of $2.60.
In the last year, Design Therapeutics(DSGN) shares hit a 52-week high of $10.31 and a 52-week low of $2.60.
People also own
Based on the portfolios of people who own DSGN. This list is generated using Robinhood data, and it’s not a recommendation.